Results | From August 1, 2015, to July 31, 2016, we retrospectively identified a total of 985 Medicare hospitalizations (mean [SD] patient age, 79.0 [8.5] years) during the same period. We identified 937 patients with actively managed HF, 468 patients by the HRRP criteria, and 355 patients by the BPCI criteria ( Figure) . We identified 507 patients (51.5%) with actively managed HF who were not captured by the HRRP or the BPCI criteria. Among these patients, the most commonly assigned DRGs were another cardiac DRG related to arrhythmia (DRG 308; 39 hospitalizations [7.7%] ), a renal DRG (DRG 682; 31 [6.1%]) , and a cardiac DRG related to cardiac catheterization (DRG 286; 30 [5.9%] ). Of the 507 hospitalizations categorized as actively managed HF only, 76 (15.0%) were observation status and excluded from the HRRP and BPCI programs; 373 (73.6%) had a secondary ICD-9 code for HF. Discussion | Our study shows that in a single large academic medical center, the 30-day HF readmission measure and BPCI initiative encompass 50% or less of the population of Medicare patients 65 years or older with actively managed HF. By selecting narrower subpopulations of patients with HF for public reporting, financial penalties, and payments rather than including the broader population experiencing HF disease burden, the HRRP and BPCI programs may promote adverse, unintended health consequences in the population excluded. Administrators and care teams may choose to focus resources on those patients for whom their institution bears financial risk, leaving important patient cohorts vulnerable to recurrent events. Alternatively, because primary ICD-9 code and DRG information are frequently assigned only after discharge, care teams may choose to design prospective programs that apply to the wider group of patients with actively managed HF, thus globally enhancing HF disease management.
We did not apply all of the exclusion criteria delineated by the Centers for Medicare & Medicaid Services for HRRP or BPCI because longitudinal data on timing of Medicare enrollment and out-of-network hospitalizations were not available. However, this lack of data likely biased our results toward an overestimation of the number of patients with HF who are identified by the readmission measure or BPCI criteria. Our data are limited to a single large academic medical center, and our findings may not extend to other medical centers.
Shifts in payment models toward value and population health management require thoughtful definition of the atrisk population. A broader understanding of the epidemiology of patients hospitalized with HF has the potential to affect a larger at-risk population.
